Skip to content

Surgery Partners, Inc. SGRY Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
HCA Healthcare logo
HCA HealthcareHCA
ARD
Ardent Health PartnersARDT
Solventum logo
SolventumSOLV
PACS Group logo
PACS GroupPACS
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.99B-49.1%

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s common stock, shares, outstanding?
Surgery Partners, Inc. (SGRY) reported common stock, shares, outstanding of $130.8M in Q1 2026.
How has Surgery Partners, Inc.'s common stock, shares, outstanding changed year-over-year?
Surgery Partners, Inc.'s common stock, shares, outstanding increased by 2.0% year-over-year, from $128.19M to $130.8M.
What is the long-term trend for Surgery Partners, Inc.'s common stock, shares, outstanding?
Over 5 years (2020 to 2025), Surgery Partners, Inc.'s common stock, shares, outstanding has grown at a 20.7% compound annual growth rate (CAGR), from $50.46M to $129.32M.